Melanoma-associated antigen B17 (MAGEB17)

Melanoma-associated antigen B17 (MAGEB17) is a predicted protein within the MAGE gene family involved in negative regulation of transcription via RNA polymerase II and is thought to function in the nucleus. Like other MAGE proteins, it is suggested to play a role in embryonic development and germ cell differentiation through the regulation of gene expression. MAGEB17 gene is located on the X chromosome and has been flagged as a potential pseudogene, with scarce evidence for bona fide protein expression in humans. Disease associations, notably melanoma and hereditary spastic paraplegia, derive from database cross-references and are not conclusive of direct functional involvement. While other MAGE proteins have been linked to oncogenesis or as immunotherapy targets due to their expression in tumors, there is insufficient evidence for MAGEB17 as a drug target or reliable biomarker. Key points: - The protein-coding status and biological relevance of MAGEB17 are uncertain; it may be a pseudogene or have only a predicted protein product. - It shares molecular and sequence features with the MAGE protein family, broadly characterized as cancer/testis antigens and transcriptional regulators. - There are no characterized drugs, drug mechanisms, or biomarkers directly linked to MAGEB17. - Safety or therapeutic concerns are not relevant, as it is not considered a therapeutic target.

Other names

MAGE family member B17Melanoma antigen family B, 17Melanoma antigen family B17MAGBH (UniProt)